Posts Tagged 'andexanet alpha'

Xarelto Reversal Agent Succeeds in Late-Stage Trial

xarelto reversal agent closer to approvalReuters reports that andexanet alfa, a drug developed by Portola Pharmaceuticals to reverse the bleeding side effects of new oral anticoagulants like Xarelto, has proven successful in a late-stage clinical trial. Portola hopes the new data will help earn the antidote approval from the U.S. Food and Drug Administration.

Xarelto is a relatively new blood thinner that has made strides in the pharmaceutical industry since its introduction in 2011. The ...

continue reading...